Telemedicine services are being adopted widely by healthcare providers during the COVID-19 pandemic to continue providing services and avoid further surge in infection rate. Policy barriers around use of telemedicine were also quickly lifted increasing its adoption. Telemedicine is expected to remain a vital part of the health visits post COVID-19.

Verdict has conducted a poll to assess whether reimbursement of telemedicine services will continue once the COVID-19 pandemic is abated.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Analysis of the results shows that the reimbursement is expected to continue after the COVID-19 pandemic abatement.

A majority of 72% of the respondents expressed confidence about the reimbursement, while the remaining 28% opined otherwise.Telemedicine reimbursement

The analysis is based on 368 responses received from the readers of Verdict’s Pharmaceutical Technology site between 18 June and 20 July.

Healthcare spending to shift towards telemedicine

Consumers of telemedicine services in the US increased to 46% compared to 11% before the COVID-19 pandemic, according to a report from McKinsey and Company, which notes that approximately $250bn in US healthcare spending is expected to shift towards telemedicine after the pandemic ends.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Effectiveness compared to in-person visits, security, and reimbursement continues to remain crucial in the future success of telemedicine services. Physicians and doctors have upheld the importance of telemedicine services even with institutions such as the American College of Rheumatology (ACR) supporting its continued use.

The ACR also supported continued reimbursement of virtual visits. The Centers for Medicare and Medicaid Services (CMS) was quick to include reimbursements for telemedicine services amid the pandemic. As consumers become more comfortable with using telemedicine services, incorporating more changes to reimbursement policies will help in increased adoption.